By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Amphastar Pharmaceuticals, Inc. (Form SC 13G) was posted on June 30, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There was one document filed with this form. The SEC file number is 0001193805-14-001340.
The contact information for this company is 11570 SIXTH STREET, RANCHO CUCAMONGA CA 91730, 909-980-9484.
Our editors provided additional information about Form SC 13G: Schedule 13G is a much abbreviated version of Schedule 13D that is only available for use by a limited category of “persons” (such as banks, broker/dealers, and insurance companies) and even then only when the securities were acquired in the ordinary course of business and not with the purpose or effect of changing or influencing the control of the issuer.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1297184/0001193805-14-001340-index.html.
Keywords for this news article include: Amphastar Pharmaceuticals Inc., Pharmaceutical Companies, Pharmaceutical Preparations, SEC Filing.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Amphastar Pharmaceuticals, Inc. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals (Jun. 30, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission
- 1 min Read
- 07.9.2014
The saying that there is no such thing as a free lunch is very much true for Robinhood.
Another Black Swan event is taking place right now. And it’s likely to have a similar effect on uranium prices.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
Of course, I couldn’t envision the extent to which AI would take off when I initially urged you to buy Nvidia.
Vulnerability depends on factors such as energy self-sufficiency, alternative energy adoption and economic resilience.
They're now able to use AI to assess data generated by everything from drills and trucks to conveyors and ships.
